FIRSTANA: Health-related quality of life (HRQL) and post-hoc analyses for the phase III study assessing cabazitaxel (C) vs docetaxel (D) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
| Affiliation auteurs | Affiliation ok |
| Titre | FIRSTANA: Health-related quality of life (HRQL) and post-hoc analyses for the phase III study assessing cabazitaxel (C) vs docetaxel (D) in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) |
| Type de publication | Journal Article |
| Year of Publication | 2016 |
| Auteurs | Oudard S., Sartor O., Sengelov L., Daugaard G., Saad F., Hansen S., Hjelm-Eriksson M., Jassem J., Thiery-Vuillemin A., Caffo O., Castellano D., Mainwaring P.N, Bernard J., Shen L., Chadjaa M., Fizazi K. |
| Journal | ANNALS OF ONCOLOGY |
| Volume | 27 |
| Date Published | OCT 1 |
| Type of Article | Meeting Abstract |
| ISSN | 0923-7534 |
| DOI | 10.1093/annonc/mdw372.5 |